DACH1 and colorectal carcinoma: The strength of our study lies in addressing this gap by combining bioinformatics analyses with multi-layered verification using clinical samples, systematically confirming the expression patterns and regulatory interactions of DACH1 and DNMT1 at critical stages of CRC progression.